MFRKX
Price
$58.66
Change
+$0.53 (+0.91%)
Updated
Jun 6 closing price
Net Assets
7.91B
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

MFRKX vs VITSX

Header iconMFRKX vs VITSX Comparison
Open Charts MFRKX vs VITSXBanner chart's image
MFS Research R6
Price$58.66
Change+$0.53 (+0.91%)
VolumeN/A
Net Assets7.91B
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
MFRKX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MFRKX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MFRKX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. MFRKX (7.91B). VITSX pays higher dividends than MFRKX: VITSX (1.29) vs MFRKX (0.78). MFRKX was incepted earlier than VITSX: MFRKX (19 years) vs VITSX (28 years). MFRKX (0.46) is less costly to investors than VITSX (0.03). MFRKX is a more actively managed with annual turnover of: 24.00 vs. VITSX (2.00). MFRKX has a lower initial minimum investment than VITSX: MFRKX (0) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 10.97 vs. MFRKX (-0.39). VITSX return over 5 years is better than : 80.96 vs. MFRKX (29.92).
MFRKXVITSXMFRKX / VITSX
Total Expense Ratio0.460.031,533%
Annual Report Gross Expense Ratio0.460.031,533%
Fund Existence19 years28 years-
Gain YTD1.0610.833127%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets7.91B1.82T0%
Annual Yield % from dividends0.781.2961%
Returns for 1 year-0.3910.97-4%
Returns for 3 years11.2040.3528%
Returns for 5 years29.9280.9637%
Returns for 10 years57.80180.4932%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.